Groupe la Francaise’s Cidara Therapeutics CDTX Stock Holding History

Groupe la Francaise’s Portfolio CDTX Stock Details CDTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-15,000	Closed	-$3.31M	–	466
2025 Q4	$3.31M	Buy	+15,000	New	+$2.42M	0.05%	216

Groupe la Francaise's CDTX Position: Q1 2026 in Review

Groupe la Francaise sold out of Cidara Therapeutics (CDTX) in Q1 2026, closing a stake of 15,000 shares — an estimated $3.31M sold.

Groupe la Francaise first reported a position in CDTX in Q4 2025 and held it in 1 quarter. The position peaked at $3.31M in Q4 2025. 0 funds tracked by Wall St. Rank hold CDTX as of Q1 2026.

Groupe la Francaise reported no remaining Cidara Therapeutics position as of Q1 2026 after selling out during the quarter.
Groupe la Francaise sold 15,000 Cidara Therapeutics shares in Q1 2026, an estimated $3.31M.
Groupe la Francaise first reported a position in Cidara Therapeutics in Q4 2025 and held it in 1 quarter.
Groupe la Francaise's Cidara Therapeutics position peaked at $3.31M in Q4 2025.
0 funds tracked by Wall St. Rank held Cidara Therapeutics as of Q1 2026.

Based on Groupe la Francaise's 13F filing for Q1 2026, filed 21 May 2026.